Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Overall ...
Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer. Demographic characteristics of patients classified according to “two-two five-five” ...
The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.
Solaiyappan et. al apply AI to analyze metabolic information contained in 1H magnetic resonance spectra to distinguish between pancreatic cancer and non-disease participants. This work presents a ...